{"id":227233,"date":"2025-12-16T17:28:16","date_gmt":"2025-12-16T23:28:16","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2025\/12\/your-body-is-full-of-medicine-researchers-can-now-synthesize-it"},"modified":"2025-12-16T17:28:16","modified_gmt":"2025-12-16T23:28:16","slug":"your-body-is-full-of-medicine-researchers-can-now-synthesize-it","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2025\/12\/your-body-is-full-of-medicine-researchers-can-now-synthesize-it","title":{"rendered":"Your body is full of medicine. Researchers can now synthesize it"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/your-body-is-full-of-medicine-researchers-can-now-synthesize-it.jpg\"><\/a><\/p>\n<p>Northeastern University researchers have made a breakthrough drug discovery, developing the first synthetic endogenous cannabinoid compound, with repercussions for new therapeutics from pain and inflammation to cancer.<\/p>\n<p>Spyros P. Nikas, an associate research professor in Northeastern\u2019s Center for Drug Discovery, says that the discovery hinges on the distinction between two different kinds of cannabinoid chemicals, endogenous and exogenous. Exogenous cannabinoids are those produced outside the human body, like THC or CBD, both derived from the cannabis plant and present in marijuana.<\/p>\n<p>Our own bodies, however, are also producing cannabinoids all the time. Called <a href=\"https:\/\/medicalxpress.com\/news\/2023-02-people-endocannabinoidssimilar-compounds-marijuanathat-critical.html?utm_source=embeddings&utm_medium=related&utm_campaign=internal\" rel=\"related\" target=\"_blank\">endogenous cannabinoids <\/a>\u2014or just \u201cendocannabinoids\u201d\u2014these chemicals \u201cmodulate a wide range of physiological and pathophysiological responses,\u201d Nikas says, processes that include mood, inflammation and even neurodegenerative disorders like Alzheimer\u2019s and Parkinson\u2019s. The research is <a href=\"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.jmedchem.5c02030\" target=\"_blank\">published<\/a> in the Journal of Medicinal Chemistry.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Northeastern University researchers have made a breakthrough drug discovery, developing the first synthetic endogenous cannabinoid compound, with repercussions for new therapeutics from pain and inflammation to cancer. Spyros P. Nikas, an associate research professor in Northeastern\u2019s Center for Drug Discovery, says that the discovery hinges on the distinction between two different kinds of cannabinoid chemicals, [\u2026]<\/p>\n","protected":false},"author":579,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,19,47],"tags":[],"class_list":["post-227233","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-chemistry","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/227233","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/579"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=227233"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/227233\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=227233"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=227233"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=227233"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}